Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Protein Expression in Samples From Young Patients With Rhabdomyosarcoma
This clinical trial update describes protein expression analyses in samples from young patients with rhabdomyosarcoma.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
A clinical trial examining protein expression in tissue samples from younger patients with alveolar rhabdomyosarcoma and embryonal rhabdomyo…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma [Phase 1]
This Phase 1 trial evaluated the combination of cixutumumab and doxorubicin in patients with unresectable, locally advanced, or metastatic s…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma
A completed clinical trial update evaluating the use of DNA tests to detect disseminated disease in tumor, blood, and bone marrow samples fr…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB [Phase 1, Phase 2]
Phase I dose-finding and safety study of LDE225 (sonidegib) in children with recurrent or refractory medulloblastoma, with a Phase II portio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients [Phase 1]
Phase 1 safety study of a recombinant vaccinia virus (JX-594/Pexa-Vec) for refractory pediatric solid tumors. The trial has completed and en…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy [NA]
Completed clinical trial evaluating the effects of preoperative physical therapy in patients with lower extremity bone sarcomas; results are…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating saracatinib (AZD0530) in adults with recurrent, locally advanced, or metastatic soft tissue sarcoma has completed…
-
CLINICAL_TRIALS research · 2015-07-27Clinical Trial Update: Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
Clinical trial update for pediatric refractory sarcomas exploring trabectedin in combination with irinotecan; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer [Phase 2]
This Phase 2 trial of sorafenib tosylate in children and young patients with relapsed or refractory rhabdomyosarcoma, Wilms tumor, hepatocel…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma [Phase 2]
Phase 2 trial evaluating cixutumumab with temsirolimus in pediatric patients with recurrent or refractory sarcomas has been completed with r…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 2]
Phase 2 trial results for cixutumumab in relapsed or refractory solid tumors across multiple sarcomas and pediatric cancers.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors [Phase 1]
A phase 1 trial evaluating everolimus in pediatric patients with recurrent or refractory tumors, including brain tumors, rhabdomyosarcoma, a…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors [Phase 1]
This dose-escalation Phase 1 trial evaluated the safety and tolerability of combining Sorafenib with Irinotecan in pediatric patients with s…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Ixabepilone in Treating Young Patients With Refractory Solid Tumors [Phase 2]
Phase 2 trial update on ixabepilone in young patients with refractory solid tumors. The study status is completed.
-
CLINICAL_TRIALS research · 2014-08-05Clinical Trial Update: Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
This entry reports the completion of a genetic study in pediatric patients with soft tissue sarcoma or rhabdomyosarcoma conducted by the Chi…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma [Phase 3]
Phase 3 trial evaluating vincristine, dactinomycin, and cyclophosphamide with or without radiation therapy in newly diagnosed low-risk rhabd…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma [Phase 2]
A Phase 2 study evaluating the combination of chemotherapy and radiation therapy for patients with metastatic rhabdomyosarcoma or other sarc…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma [Phase 3]
A Phase 3 trial evaluating whether adding radiation therapy to standard combination chemotherapy improves outcomes in newly diagnosed rhabdo…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features [Phase 1]
Phase 1 clinical trial update for Seneca Valley Virus-001 with Cyclophosphamide in pediatric patients with relapsed/refractory neuroblastoma…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors [Phase 2]
Phase 2 clinical trial evaluating trabectedin in young patients with recurrent or refractory soft tissue sarcoma or Ewing's family tumors; s…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma [Phase 3]
Phase 3 trial evaluating high-dose combination chemotherapy with radiation therapy for newly diagnosed metastatic rhabdomyosarcoma or ectome…
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for pediatric metastatic rhabdomyosarcoma and other malignant mesenchymal tumors; …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]
Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma [Phase 1, Phase 2]
An update on a National Cancer Institute–sponsored Phase 1/Phase 2 trial evaluating a therapy for Ewing sarcoma, rhabdomyosarcoma, and neuro…